Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$13,399,830
+$1,304,559 QoQ
Shares Held
53,250
-4.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#782
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABELLI FUNDS LLC holds $287,466,952 across 14 Drug Manufacturers - General names. ABBV ranks #6 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
104,112 | $124,875,066 | |
| 2 | MRK |
Merck & Co., Inc.
|
288,700 | $37,097,950 | |
| 3 | JNJ |
Johnson & Johnson
|
127,317 | $32,334,698 | |
| 4 | AMGN |
Amgen Inc
|
55,700 | $20,170,084 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
256,790 | $14,796,239 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
53,250 | $13,399,830 | |
| 7 | OGN |
Organon & Co.
|
954,910 | $12,929,481 | |
| 8 | PFE |
Pfizer Inc
|
501,500 | $12,076,120 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,399,830 | 53,250 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $12,095,271 | 55,613 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $18,556,358 | 81,213 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $23,376,973 | 100,963 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $19,984,406 | 107,663 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $23,982,287 | 114,463 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $21,326,310 | 120,013 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $27,271,988 | 138,100 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $23,995,648 | 139,900 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $25,412,055 | 139,550 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $22,052,231 | 142,300 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $21,390,110 | 143,500 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $19,286,599 | 143,150 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $22,981,154 | 144,200 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $22,124,409 | 136,900 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $18,913,544 | 140,925 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $21,396,452 | 139,700 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $20,967,307 | 129,340 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $19,211,906 | 141,890 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $14,105,620 | 130,765 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $13,020,057 | 115,590 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $12,271,065 | 113,390 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $8,839,446 | 82,496 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $5,745,553 | 65,596 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $7,225,655 | 73,596 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $632,377 | 8,300 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||